Condition: Breast Cancer · Sponsor: Memorial Sloan Kettering Cancer Center
The purpose of this study is to compare using FDA-approved bupivacaine (a numbing medicine), along with the usual medications for post-operative pain control to using the usual medications for postoperative pain control alone. The addition of bupivacaine to the surgical wound site with the usual pain medications could better manage your pain immediately after surgery and reduce the amount of opioid medications taken after surgery. This study will allow the researchers to know whether this different approach is better, the same, or worse than the usual approach.
This description comes directly from the study's public registry record.
Laurie Kirstein, MD · 848-225-6121 · kirsteil@mskcc.org
Leslie Sarraf, MD · 212-639-8415
Always discuss trial participation with your own doctor first.
| Memorial Sloan Kettering Basking Ridge (Consent and follow-up only) | Basking Ridge, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Monmouth (All Protocol Activities) | Middletown, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Bergen (Consent and follow-up only) | Montvale, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Commack (Consent and follow-up only) | Commack, New York, United States | Recruiting |
| Memorial Sloan Kettering Westchester (Consent and follow-up only) | Harrison, New York, United States | Recruiting |
| Memorial Sloan Kettering Cancer Center | New York, New York, United States | Recruiting |
| Memorial Sloan Kettering Nassau (Consent and follow-up only) | Uniondale, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03351348